instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'IRINOTECAN'? | Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center.
Pancreatic cancer is one of the most lethal cancers. To improve its prognosis, conversion surgery for initially unresectable advanced pancreatic cancer (UAP... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34199125 | 20,111,369 | 2021-06-27 |
What was the administration route of drug 'LEUCOVORIN'? | Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center.
Pancreatic cancer is one of the most lethal cancers. To improve its prognosis, conversion surgery for initially unresectable advanced pancreatic cancer (UAP... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34199125 | 20,111,369 | 2021-06-27 |
What was the administration route of drug 'OXALIPLATIN'? | Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center.
Pancreatic cancer is one of the most lethal cancers. To improve its prognosis, conversion surgery for initially unresectable advanced pancreatic cancer (UAP... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34199125 | 20,111,369 | 2021-06-27 |
What was the dosage of drug 'IRINOTECAN HYDROCHLORIDE'? | Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center.
Pancreatic cancer is one of the most lethal cancers. To improve its prognosis, conversion surgery for initially unresectable advanced pancreatic cancer (UAP... | 150 MG/M2, CYCLIC (FOR 90 MIN) | DrugDosageText | CC BY | 34199125 | 19,998,872 | 2021-06-27 |
What was the dosage of drug 'IRINOTECAN'? | Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center.
Pancreatic cancer is one of the most lethal cancers. To improve its prognosis, conversion surgery for initially unresectable advanced pancreatic cancer (UAP... | 150 MILLIGRAM/SQ. METER FOR 90 MIN., UNK | DrugDosageText | CC BY | 34199125 | 20,111,369 | 2021-06-27 |
What was the outcome of reaction 'Disease recurrence'? | Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center.
Pancreatic cancer is one of the most lethal cancers. To improve its prognosis, conversion surgery for initially unresectable advanced pancreatic cancer (UAP... | Fatal | ReactionOutcome | CC BY | 34199125 | 20,111,369 | 2021-06-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrioventricular block first degree'. | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | AMIODARONE, FLECAINIDE | DrugsGivenReaction | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiotoxicity'. | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | AMIODARONE, FLECAINIDE | DrugsGivenReaction | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | AMIODARONE, FLECAINIDE | DrugsGivenReaction | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QRS complex prolonged'. | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | AMIODARONE, FLECAINIDE | DrugsGivenReaction | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | AMIODARONE, FLECAINIDE | DrugsGivenReaction | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular tachycardia'. | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | AMIODARONE, FLECAINIDE | DrugsGivenReaction | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
What was the administration route of drug 'FLECAINIDE'? | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | Oral | DrugAdministrationRoute | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
What was the dosage of drug 'FLECAINIDE'? | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | 5000 mg (milligrams). | DrugDosage | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
What was the outcome of reaction 'Atrioventricular block first degree'? | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | Recovered | ReactionOutcome | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
What was the outcome of reaction 'Cardiotoxicity'? | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | Recovered | ReactionOutcome | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
What was the outcome of reaction 'Drug interaction'? | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | Recovered | ReactionOutcome | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
What was the outcome of reaction 'Electrocardiogram QRS complex prolonged'? | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | Recovered | ReactionOutcome | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
What was the outcome of reaction 'Toxicity to various agents'? | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | Recovered | ReactionOutcome | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
What was the outcome of reaction 'Ventricular tachycardia'? | First Case of Acute Poisoning with Amiodarone and Flecainide in Attempted Suicide Successfully Managed with Lipid Emulsion Therapy in the Emergency Department: Case Report and Literature Review.
Acute antiarrhythmics poisoning represents a challenge in the Emergency Department (ED). These patients often develop maligna... | Recovered | ReactionOutcome | CC BY | 34199756 | 19,588,597 | 2021-06-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug abuse'. | Acute Myocardial Injury in a Patient with Attention Deficit Hyperactivity Disorder and History of Substance Abuse: A Multimodality Imaging Point of View.
Both cannabis and amphetamine are the most commonly used illegal substances worldwide and are associated with a number of adverse cardiovascular effects including tra... | AMPHETAMINE SULFATE, CANNABIS SATIVA SUBSP. INDICA TOP, LISDEXAMFETAMINE DIMESYLATE | DrugsGivenReaction | CC BY | 34200122 | 19,503,315 | 2021-06-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Heart injury'. | Acute Myocardial Injury in a Patient with Attention Deficit Hyperactivity Disorder and History of Substance Abuse: A Multimodality Imaging Point of View.
Both cannabis and amphetamine are the most commonly used illegal substances worldwide and are associated with a number of adverse cardiovascular effects including tra... | AMPHETAMINE SULFATE, LISDEXAMFETAMINE DIMESYLATE | DrugsGivenReaction | CC BY | 34200122 | 19,499,114 | 2021-06-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stress cardiomyopathy'. | Acute Myocardial Injury in a Patient with Attention Deficit Hyperactivity Disorder and History of Substance Abuse: A Multimodality Imaging Point of View.
Both cannabis and amphetamine are the most commonly used illegal substances worldwide and are associated with a number of adverse cardiovascular effects including tra... | AMPHETAMINE SULFATE, CANNABIS SATIVA SUBSP. INDICA TOP, LISDEXAMFETAMINE DIMESYLATE | DrugsGivenReaction | CC BY | 34200122 | 19,503,315 | 2021-06-07 |
What was the outcome of reaction 'Electrocardiogram ST segment elevation'? | Acute Myocardial Injury in a Patient with Attention Deficit Hyperactivity Disorder and History of Substance Abuse: A Multimodality Imaging Point of View.
Both cannabis and amphetamine are the most commonly used illegal substances worldwide and are associated with a number of adverse cardiovascular effects including tra... | Recovered | ReactionOutcome | CC BY | 34200122 | 19,499,114 | 2021-06-07 |
What was the outcome of reaction 'Stress cardiomyopathy'? | Acute Myocardial Injury in a Patient with Attention Deficit Hyperactivity Disorder and History of Substance Abuse: A Multimodality Imaging Point of View.
Both cannabis and amphetamine are the most commonly used illegal substances worldwide and are associated with a number of adverse cardiovascular effects including tra... | Recovering | ReactionOutcome | CC BY | 34200122 | 19,503,315 | 2021-06-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypovolaemia'. | Usefulness of the Electrocardiogram in a Patient Presenting with Right-Sided Pneumothorax and Presyncope.
We present the case of a 71-year-old man with history of smoking, pulmonary emphysema, hypertension, multivessel coronary artery disease and prior coronary artery bypass graft surgery who presented with spontaneous... | ASPIRIN, ATORVASTATIN, BISOPROLOL, CLONIDINE, FUROSEMIDE, NITROGLYCERIN, SPIRONOLACTONE, VALSARTAN | DrugsGivenReaction | CC BY | 34200664 | 19,973,522 | 2021-06-10 |
What was the outcome of reaction 'Hypovolaemia'? | Usefulness of the Electrocardiogram in a Patient Presenting with Right-Sided Pneumothorax and Presyncope.
We present the case of a 71-year-old man with history of smoking, pulmonary emphysema, hypertension, multivessel coronary artery disease and prior coronary artery bypass graft surgery who presented with spontaneous... | Recovered | ReactionOutcome | CC BY | 34200664 | 19,973,522 | 2021-06-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report.
A 32-year-old woman with chemorefractory mullerian adenosarcoma showed clinical benefit in response to administration of lenvatinib plus pembrolizumab. In this case report, we describe the course of her illness and her... | DOCETAXEL, GEMCITABINE | DrugsGivenReaction | CC BY | 34200874 | 20,010,552 | 2021-06-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report.
A 32-year-old woman with chemorefractory mullerian adenosarcoma showed clinical benefit in response to administration of lenvatinib plus pembrolizumab. In this case report, we describe the course of her illness and her... | DOCETAXEL, GEMCITABINE | DrugsGivenReaction | CC BY | 34200874 | 20,010,552 | 2021-06-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report.
A 32-year-old woman with chemorefractory mullerian adenosarcoma showed clinical benefit in response to administration of lenvatinib plus pembrolizumab. In this case report, we describe the course of her illness and her... | DOCETAXEL, GEMCITABINE | DrugsGivenReaction | CC BY | 34200874 | 20,010,552 | 2021-06-10 |
What is the weight of the patient? | Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report.
A 32-year-old woman with chemorefractory mullerian adenosarcoma showed clinical benefit in response to administration of lenvatinib plus pembrolizumab. In this case report, we describe the course of her illness and her... | 85 kg. | Weight | CC BY | 34200874 | 20,010,552 | 2021-06-10 |
What was the dosage of drug 'DOCETAXEL'? | Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report.
A 32-year-old woman with chemorefractory mullerian adenosarcoma showed clinical benefit in response to administration of lenvatinib plus pembrolizumab. In this case report, we describe the course of her illness and her... | 75 MG/M2, Q3W (DAY 8) 5 CYCLES | DrugDosageText | CC BY | 34200874 | 20,010,552 | 2021-06-10 |
What was the dosage of drug 'GEMCITABINE'? | Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report.
A 32-year-old woman with chemorefractory mullerian adenosarcoma showed clinical benefit in response to administration of lenvatinib plus pembrolizumab. In this case report, we describe the course of her illness and her... | 900 MG/M2 (DAYS 1 AND 8) 5 CYCLES | DrugDosageText | CC BY | 34200874 | 20,010,552 | 2021-06-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the pa... | ASPIRIN, BENDAMUSTINE, BISOPROLOL, DIGOXIN, FLECAINIDE, FLUINDIONE, ILOPROST, RITUXIMAB | DrugsGivenReaction | CC BY | 34201186 | 19,525,409 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the pa... | ASPIRIN, BENDAMUSTINE, BISOPROLOL, DIGOXIN, FLECAINIDE, FLUINDIONE, ILOPROST, RITUXIMAB | DrugsGivenReaction | CC BY | 34201186 | 19,525,409 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematoma'. | Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the pa... | ASPIRIN, BENDAMUSTINE, BISOPROLOL, DIGOXIN, FLECAINIDE, FLUINDIONE, ILOPROST, RITUXIMAB | DrugsGivenReaction | CC BY | 34201186 | 19,525,409 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the pa... | ASPIRIN, BENDAMUSTINE, BISOPROLOL, DIGOXIN, FLECAINIDE, FLUINDIONE, ILOPROST, RITUXIMAB | DrugsGivenReaction | CC BY | 34201186 | 19,525,409 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Necrosis'. | Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the pa... | ASPIRIN, BENDAMUSTINE, BISOPROLOL, DIGOXIN, FLECAINIDE, FLUINDIONE, ILOPROST, RITUXIMAB | DrugsGivenReaction | CC BY | 34201186 | 19,525,409 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the pa... | ASPIRIN, BENDAMUSTINE, BISOPROLOL, DIGOXIN, FLECAINIDE, FLUINDIONE, ILOPROST, RITUXIMAB | DrugsGivenReaction | CC BY | 34201186 | 19,525,409 | 2021-06-08 |
What was the administration route of drug 'ILOPROST'? | Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the pa... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34201186 | 19,525,409 | 2021-06-08 |
What was the dosage of drug 'ILOPROST'? | Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the pa... | 0.5 ML/H (COULD NOT BE INCREASED DUE TO THE PATIENT^S INTOLERANCE) | DrugDosageText | CC BY | 34201186 | 19,525,409 | 2021-06-08 |
What was the outcome of reaction 'Death'? | Frostbite and Cold Agglutinin Disease: Coexistence of Two Entities Leading to Poor Clinical Outcomes.
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the pa... | Fatal | ReactionOutcome | CC BY | 34201186 | 19,525,409 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Emergency Use of Targeted Osmotic Lysis for the Treatment of a Patient with Aggressive Late-Stage Squamous Cell Carcinoma of the Cervix.
Upregulation of voltage-gated sodium channels (VGSCs) and Na+/K+-ATPase (sodium pumps) is common across most malignant carcinomas. Targeted osmotic lysis (TOL) is a developing technol... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34201380 | 19,827,505 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Emergency Use of Targeted Osmotic Lysis for the Treatment of a Patient with Aggressive Late-Stage Squamous Cell Carcinoma of the Cervix.
Upregulation of voltage-gated sodium channels (VGSCs) and Na+/K+-ATPase (sodium pumps) is common across most malignant carcinomas. Targeted osmotic lysis (TOL) is a developing technol... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34201380 | 19,827,505 | 2021-06-08 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Emergency Use of Targeted Osmotic Lysis for the Treatment of a Patient with Aggressive Late-Stage Squamous Cell Carcinoma of the Cervix.
Upregulation of voltage-gated sodium channels (VGSCs) and Na+/K+-ATPase (sodium pumps) is common across most malignant carcinomas. Targeted osmotic lysis (TOL) is a developing technol... | 4 CYCLES | DrugDosageText | CC BY | 34201380 | 19,827,505 | 2021-06-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis.
The effect of preoperative immunonutrition intake on postoperative major complications in patients following cytoreductive surgery (CRS) with or without hyperthermic intr... | MITOMYCIN, OXALIPLATIN | DrugsGivenReaction | CC BY | 34201458 | 19,955,942 | 2021-06-23 |
What was the outcome of reaction 'Death'? | Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis.
The effect of preoperative immunonutrition intake on postoperative major complications in patients following cytoreductive surgery (CRS) with or without hyperthermic intr... | Fatal | ReactionOutcome | CC BY | 34201458 | 19,955,942 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.
A 59-year-old male with follicular lymphoma treated by anti-CD20-mediated B-cell depletion and ablative chemotherapy was hospitalized with a C... | AZITHROMYCIN ANHYDROUS, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, METHYLPREDNISOLONE SODIUM SUCCINATE | DrugsGivenReaction | CC BY | 34201591 | 19,824,911 | 2021-06-23 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.
A 59-year-old male with follicular lymphoma treated by anti-CD20-mediated B-cell depletion and ablative chemotherapy was hospitalized with a C... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34201591 | 19,824,911 | 2021-06-23 |
What was the dosage of drug 'LOPINAVIR\RITONAVIR'? | Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.
A 59-year-old male with follicular lymphoma treated by anti-CD20-mediated B-cell depletion and ablative chemotherapy was hospitalized with a C... | UNK (200/50 MG TABLETS, TWO TABLETS BID) | DrugDosageText | CC BY | 34201591 | 19,824,911 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blindness transient'. | Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study.
The aim of the present study was to determine the efficacy and safety of intravitreal brolucizumab therapy for neovascular age-related macular degeneration (AMD) in the real-world setting. The REBA study (real-world experie... | BROLUCIZUMAB-DBLL | DrugsGivenReaction | CC BY | 34201729 | 18,752,539 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Macular hole'. | Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study.
The aim of the present study was to determine the efficacy and safety of intravitreal brolucizumab therapy for neovascular age-related macular degeneration (AMD) in the real-world setting. The REBA study (real-world experie... | BROLUCIZUMAB-DBLL | DrugsGivenReaction | CC BY | 34201729 | 18,752,539 | 2021-06-23 |
What was the administration route of drug 'BROLUCIZUMAB-DBLL'? | Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study.
The aim of the present study was to determine the efficacy and safety of intravitreal brolucizumab therapy for neovascular age-related macular degeneration (AMD) in the real-world setting. The REBA study (real-world experie... | Intraocular | DrugAdministrationRoute | CC BY | 34201729 | 18,752,539 | 2021-06-23 |
What was the dosage of drug 'BROLUCIZUMAB-DBLL'? | Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study.
The aim of the present study was to determine the efficacy and safety of intravitreal brolucizumab therapy for neovascular age-related macular degeneration (AMD) in the real-world setting. The REBA study (real-world experie... | UNK UNK, UNKNOWN | DrugDosageText | CC BY | 34201729 | 18,752,539 | 2021-06-23 |
What was the outcome of reaction 'Blindness transient'? | Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study.
The aim of the present study was to determine the efficacy and safety of intravitreal brolucizumab therapy for neovascular age-related macular degeneration (AMD) in the real-world setting. The REBA study (real-world experie... | Recovering | ReactionOutcome | CC BY | 34201729 | 18,752,539 | 2021-06-23 |
What was the outcome of reaction 'Macular hole'? | Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study.
The aim of the present study was to determine the efficacy and safety of intravitreal brolucizumab therapy for neovascular age-related macular degeneration (AMD) in the real-world setting. The REBA study (real-world experie... | Recovered | ReactionOutcome | CC BY | 34201729 | 18,752,539 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic villitis of unknown etiology'. | Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease that causes thrombocytopenia and a risk of bleeding in the (unborn) child that result from maternal alloantibodies directed against fetal, patern... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 34201864 | 19,638,206 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease that causes thrombocytopenia and a risk of bleeding in the (unborn) child that result from maternal alloantibodies directed against fetal, patern... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 34201864 | 19,638,206 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal distress syndrome'. | Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease that causes thrombocytopenia and a risk of bleeding in the (unborn) child that result from maternal alloantibodies directed against fetal, patern... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 34201864 | 19,666,976 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease that causes thrombocytopenia and a risk of bleeding in the (unborn) child that result from maternal alloantibodies directed against fetal, patern... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 34201864 | 19,666,976 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intrauterine infection'. | Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease that causes thrombocytopenia and a risk of bleeding in the (unborn) child that result from maternal alloantibodies directed against fetal, patern... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 34201864 | 19,638,206 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease that causes thrombocytopenia and a risk of bleeding in the (unborn) child that result from maternal alloantibodies directed against fetal, patern... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 34201864 | 19,638,206 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease that causes thrombocytopenia and a risk of bleeding in the (unborn) child that result from maternal alloantibodies directed against fetal, patern... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 34201864 | 19,638,206 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Placental disorder'. | Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease that causes thrombocytopenia and a risk of bleeding in the (unborn) child that result from maternal alloantibodies directed against fetal, patern... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 34201864 | 19,638,206 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Placental insufficiency'. | Placental Complement Activation in Fetal and Neonatal Alloimmune Thrombocytopenia: An Observational Study.
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a disease that causes thrombocytopenia and a risk of bleeding in the (unborn) child that result from maternal alloantibodies directed against fetal, patern... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 34201864 | 19,638,206 | 2021-06-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered f... | CARVEDILOL, CYCLOPHOSPHAMIDE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, MYCOPHENOLATE MOFETIL, PLERIXAFOR, PREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34201939 | 19,782,257 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered f... | CARVEDILOL, CYCLOPHOSPHAMIDE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, MYCOPHENOLATE MOFETIL, PLERIXAFOR, PREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34201939 | 19,782,257 | 2021-06-25 |
What was the administration route of drug 'RITUXIMAB'? | Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered f... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34201939 | 19,782,257 | 2021-06-25 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered f... | 7.5 MG/KG | DrugDosageText | CC BY | 34201939 | 19,782,257 | 2021-06-25 |
What was the dosage of drug 'GRANULOCYTE COLONY-STIMULATING FACTOR NOS'? | Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered f... | 10 UG/KG | DrugDosageText | CC BY | 34201939 | 19,782,257 | 2021-06-25 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered f... | {UNKNOWN} | DrugDosageText | CC BY | 34201939 | 19,782,257 | 2021-06-25 |
What was the dosage of drug 'PLERIXAFOR'? | Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered f... | 0.24 MG/KG | DrugDosageText | CC BY | 34201939 | 19,782,257 | 2021-06-25 |
What was the dosage of drug 'PREDNISOLONE'? | Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered f... | 1 MG/KG | DrugDosageText | CC BY | 34201939 | 19,782,257 | 2021-06-25 |
What was the outcome of reaction 'Pneumonia'? | Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Systemic sclerosis (SSc) is an intractable autoimmune disease characterized by vasculopathy and organ fibrosis. Autologous hematopoietic stem cell transplantation (AHSCT) should be considered f... | Recovering | ReactionOutcome | CC BY | 34201939 | 19,782,257 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterococcal infection'. | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | AZATHIOPRINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 34201947 | 20,111,397 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterococcus test positive'. | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | AZATHIOPRINE, CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY | 34201947 | 20,027,420 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella infection'. | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY | 34201947 | 20,027,419 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia klebsiella'. | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY | 34201947 | 20,006,770 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY | 34201947 | 20,006,770 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteus infection'. | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY | 34201947 | 20,027,419 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | CYCLOSPORINE, EVEROLIMUS, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY | 34201947 | 20,111,398 | 2021-06-25 |
What was the dosage of drug 'CYCLOSPORINE'? | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | UNKNOWN, UNKNOWN | DrugDosageText | CC BY | 34201947 | 20,224,005 | 2021-06-25 |
What was the dosage of drug 'EVEROLIMUS'? | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | UNKNOWN, UNKNOWN | DrugDosageText | CC BY | 34201947 | 20,224,005 | 2021-06-25 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | UNKNOWN, UNKNOWN | DrugDosageText | CC BY | 34201947 | 20,224,005 | 2021-06-25 |
What was the dosage of drug 'PREDNISOLONE'? | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | UNKNOWN, UNKNOWN | DrugDosageText | CC BY | 34201947 | 20,224,005 | 2021-06-25 |
What was the outcome of reaction 'Cytomegalovirus infection reactivation'? | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | Fatal | ReactionOutcome | CC BY | 34201947 | 20,021,878 | 2021-06-25 |
What was the outcome of reaction 'Shock'? | SARS-CoV-2 and Cytomegalovirus Co-Infections-A Case Series of Critically Ill Patients.
The SARS-CoV-2 pandemic has placed great strain on the most developed of health care systems, especially in the context of critical care. Although co-infections with cytomegalovirus (CMV) are frequent in the critically ill due to und... | Fatal | ReactionOutcome | CC BY | 34201947 | 20,021,878 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | PREDNISONE, RITUXIMAB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34202156 | 19,788,684 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | PREDNISONE, RITUXIMAB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34202156 | 19,788,684 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hairy cell leukaemia'. | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | PREDNISONE, RITUXIMAB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34202156 | 19,788,684 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | CLADRIBINE, FILGRASTIM, MOXETUMOMAB PASUDOTOX, RITUXIMAB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34202156 | 19,520,116 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutrophil count decreased'. | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | CLADRIBINE, FILGRASTIM, MOXETUMOMAB PASUDOTOX, RITUXIMAB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34202156 | 19,520,116 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | CLADRIBINE, FILGRASTIM, MOXETUMOMAB PASUDOTOX, RITUXIMAB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34202156 | 19,520,116 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pseudomonas infection'. | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | CLADRIBINE, FILGRASTIM, MOXETUMOMAB PASUDOTOX, RITUXIMAB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34202156 | 19,520,116 | 2021-06-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | CLADRIBINE, FILGRASTIM, MOXETUMOMAB PASUDOTOX, RITUXIMAB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34202156 | 19,520,116 | 2021-06-25 |
What was the administration route of drug 'CLADRIBINE'? | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34202156 | 19,520,116 | 2021-06-25 |
What was the administration route of drug 'MOXETUMOMAB PASUDOTOX'? | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34202156 | 19,520,116 | 2021-06-25 |
What was the administration route of drug 'RITUXIMAB'? | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34202156 | 19,788,684 | 2021-06-25 |
What was the administration route of drug 'VEMURAFENIB'? | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | Oral | DrugAdministrationRoute | CC BY | 34202156 | 19,520,116 | 2021-06-25 |
What was the dosage of drug 'CLADRIBINE'? | Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.
The purine nucleoside analogues cladribine and pentostatin are highly-active first-line therapeutic treatments for hairy cell leukemia (HCL), resulting in complete response rates of 80% to 90%. However, HCL pat... | 0.12 MG/KG, DAILY FOR FIVE DAYS EACH | DrugDosageText | CC BY | 34202156 | 19,520,116 | 2021-06-25 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.